Intellipharmaceutics Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INTELLIPHARMACEUTICS, and what generic and branded alternatives to INTELLIPHARMACEUTICS drugs are available?
INTELLIPHARMACEUTICS has five approved drugs.
Summary for Intellipharmaceutics
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
| Patent Litigation for Intellipharmaceutics: | See patent lawsuits for Intellipharmaceutics |
Drugs and US Patents for Intellipharmaceutics
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intellipharmaceutics | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 202939-002 | May 9, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Intellipharmaceutics | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 202939-001 | May 9, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Intellipharmaceutics | DEXMETHYLPHENIDATE HYDROCHLORIDE | dexmethylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 078992-004 | Nov 18, 2013 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Intellipharmaceutics | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 202306-002 | Feb 23, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
